rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2003-2-24
|
pubmed:abstractText |
The authors previously identified elevated caveolin-1 expression in human prostate carcinoma and determined that caveolin-1 levels as detected by immunohistochemistry of radical prostatectomy specimens offered novel prognostic information. A higher incidence of caveolin-1 expression also was reported in African-American men compared with white men in the U.S. To explore these ethnic/racial differences in caveolin-1 expression further, the authors evaluated caveolin-1 expression as a predictive marker in Japanese men with prostate carcinoma.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2003 American Cancer Society.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1225-33
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12599229-Aged,
pubmed-meshheading:12599229-Caveolin 1,
pubmed-meshheading:12599229-Caveolins,
pubmed-meshheading:12599229-Disease Progression,
pubmed-meshheading:12599229-Disease-Free Survival,
pubmed-meshheading:12599229-Ethnic Groups,
pubmed-meshheading:12599229-Humans,
pubmed-meshheading:12599229-Immunohistochemistry,
pubmed-meshheading:12599229-Incidence,
pubmed-meshheading:12599229-Japan,
pubmed-meshheading:12599229-Male,
pubmed-meshheading:12599229-Middle Aged,
pubmed-meshheading:12599229-Neoplasm Recurrence, Local,
pubmed-meshheading:12599229-Prognosis,
pubmed-meshheading:12599229-Proportional Hazards Models,
pubmed-meshheading:12599229-Prostate-Specific Antigen,
pubmed-meshheading:12599229-Prostatic Neoplasms,
pubmed-meshheading:12599229-Survival Analysis,
pubmed-meshheading:12599229-Tumor Markers, Biological
|
pubmed:year |
2003
|
pubmed:articleTitle |
Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.
|
pubmed:affiliation |
Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Evaluation Studies
|